Immunoreactivity of CD10 and inhibin alpha in differentiating hemangioblastoma of central nervous system from metastatic clear cell renal cell carcinoma
- 1 June 2005
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 18 (6) , 788-794
- https://doi.org/10.1038/modpathol.3800351
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- CD10 Expression in Epithelial Tissues and Tumors of the Gynecologic TractThe American Journal of Surgical Pathology, 2003
- Diagnosing Primary and Metastatic Renal Cell CarcinomaThe American Journal of Surgical Pathology, 2001
- Cytokeratin 7 and Cytokeratin 20 Expression in Epithelial Neoplasms: A Survey of 435 CasesLaboratory Investigation, 2000
- Paraffin-Section Detection of CD10 in 505 Nonhematopoietic NeoplasmsAmerican Journal of Clinical Pathology, 2000
- Neuroendocrine Differentiation in Renal Cell Carcinoma: Evaluation of Chromogranin A and Neuron-Specific EnolaseActa Oncologica, 1999
- CD10Applied Immunohistochemistry & Molecular Morphology, 1997
- Immunohistochemistry of Capillary HemangioblastomaThe American Journal of Surgical Pathology, 1989
- Use of immunohistochemical methods in the differential diagnosis between primary cerebellar haemangioblastoma and metastatic renal carcinoma.Journal of Clinical Pathology, 1988
- Von Hippel–Lindau disease maps to the region of chromosome 3 associated with renal cell carcinomaNature, 1988
- Immunoperoxidase labelled antibody staining in differential diagnosis of central nervous system haemangioblastomas and central nervous system metastases of renal carcinomas.Journal of Clinical Pathology, 1986